Non-immune-based treatment for type 1 diabetes: the way to go?

Lancet Diabetes Endocrinol. 2014 Sep;2(9):681-2. doi: 10.1016/S2213-8587(14)70139-1. Epub 2014 Jul 2.

Author

Affiliation

¹ Department of Pediatrics, Indiana University and Riley Hospital for Children, Indianapolis, IN 46202-5225, USA. Electronic address: mrigby@iu.edu.

PMID: 24997558
DOI: 10.1016/S2213-8587(14)70139-1

No abstract available

MeSH terms

Diabetes Mellitus, Type 1 / drug therapy*
Dipeptidyl-Peptidase IV Inhibitors / therapeutic use*
Humans
Insulin-Secreting Cells / drug effects*
Proton Pump Inhibitors / therapeutic use*

Substances

Dipeptidyl-Peptidase IV Inhibitors
Proton Pump Inhibitors